NDC properties for "0.1 ML Humira 100 MG/ML Prefilled Syringe" (RxCUI 1921010)
About this data
The tables show NDC propoerties for 0.1 ML Humira 100 MG/ML Prefilled Syringe with the RxCUI 1921010
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.1 ML Humira 100 MG/ML Prefilled Syringe (RxCUI 1921010)
| BLA | BLA125057 |
|---|---|
| MMSL_CODE | BD33111 |
| RxCUI | 1921010 |
| SPL_SET_ID | 4977567e-3525-44ac-9ff5-f1e74b053950 |
| SPL_SET_ID | 608d4f0d-b19f-46d3-749a-7159aa5f933d |
| Prescribable Synonym | Humira 10 MG in 0.1 ML Prefilled Syringe |
| RXNAV_STR | 0.1 ML Humira 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.1 ML adalimumab 100 MG/ML Prefilled Syringe [Humira] |
| RxNorm Synonym | 0.1 ML Humira 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | Humira 10 MG per 0.1 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 1921010) |
NDC Properties
NDC Item 00074081702
| NDC 9 | 0074-0817 |
|---|---|
| NDC 10 | 0074-0817-02 |
| NDC Item | 00074081702 |
| Packaging | 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0817 |
NDC Item 83457081601
| NDC 9 | 83457-816 |
|---|---|
| NDC 10 | 83457-816-01 |
| NDC Item | 83457081601 |
| Packaging | 0.1 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-816 |
NDC Item 83457081702
| NDC 9 | 83457-817 |
|---|---|
| NDC 10 | 83457-817-02 |
| NDC Item | 83457081702 |
| Packaging | 2 KIT in 1 CARTON (83457-817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-816-01) / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-817 |
NDC Item 00074081702
| NDC 9 | 0074-0817 |
|---|---|
| NDC 10 | 0074-0817-02 |
| NDC Item | 00074081702 |
| Packaging | 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0817 |
NDC Item 83457081601
| NDC 9 | 83457-816 |
|---|---|
| NDC 10 | 83457-816-01 |
| NDC Item | 83457081601 |
| Packaging | 0.1 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-816 |
NDC Item 83457081702
| NDC 9 | 83457-817 |
|---|---|
| NDC 10 | 83457-817-02 |
| NDC Item | 83457081702 |
| Packaging | 2 KIT in 1 CARTON (83457-817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-816-01) / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-817 |
NDC Item 00074081702
| NDC 9 | 0074-0817 |
|---|---|
| NDC 10 | 0074-0817-02 |
| NDC Item | 00074081702 |
| Packaging | 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0817 |
NDC Item 83457081601
| NDC 9 | 83457-816 |
|---|---|
| NDC 10 | 83457-816-01 |
| NDC Item | 83457081601 |
| Packaging | 0.1 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-816 |
NDC Item 83457081702
| NDC 9 | 83457-817 |
|---|---|
| NDC 10 | 83457-817-02 |
| NDC Item | 83457081702 |
| Packaging | 2 KIT in 1 CARTON (83457-817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-816-01) / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-817 |